CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,083,813 | -38.7% | 324,499 | -10.8% | 0.00% | -50.0% |
Q2 2023 | $11,562,150 | +25.7% | 363,704 | -3.5% | 0.00% | 0.0% |
Q1 2023 | $9,196,421 | -5.0% | 377,057 | +22.8% | 0.00% | 0.0% |
Q4 2022 | $9,681,203 | +39.4% | 306,950 | +24.9% | 0.00% | 0.0% |
Q3 2022 | $6,946,000 | +159.9% | 245,797 | +143.1% | 0.00% | +100.0% |
Q2 2022 | $2,673,000 | -7.2% | 101,104 | +22.9% | 0.00% | 0.0% |
Q1 2022 | $2,880,000 | -78.9% | 82,265 | -80.5% | 0.00% | -66.7% |
Q4 2021 | $13,671,000 | -9.1% | 421,688 | -17.3% | 0.00% | 0.0% |
Q3 2021 | $15,038,000 | +475.7% | 509,747 | +167.9% | 0.00% | +200.0% |
Q1 2021 | $2,612,000 | +456.9% | 190,266 | +572.1% | 0.00% | – |
Q4 2020 | $469,000 | – | 28,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |